Bausch Health Announces Positive Topline Results From Global

Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis

Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis
torontotelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from torontotelegraph.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , Canada , Canadian , British , Thomasj Appio , Kevin Wiggins , Kunio Sugahara , Lisa Wilson , Yasuhiro Maeda , Linkedin , Pharmacological Research , Lomb Corporation , Bausch Health Companies Inc , Exchange Commission , Company Phase , Bausch Health , Trial Meets Both Primary , Key Secondary , Bausch Health Companies , Chief Executive Officer , Mayo Score , Health Companies , Canadian Securities Administrators , Ronald Christopher Modulation , Canada Wire Group ,